Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Recent multi‑patient studies have highlighted TOMM70 as a candidate gene in the context of COVID‑19 (PMID:34530086, PMID:38902252). Although direct genetic evidence from large cohorts or familial segregation analyses is limited, TOMM70 is recurrently identified as part of the SARS‑CoV‑2 host interactome. In these studies, TOMM70 was nominated based on protein‑protein interaction data and computational models predicting its potential role in viral pathogenicity and immune modulation. The evidence supports an association where TOMM70 may influence disease susceptibility by its involvement in mitochondrial import processes and the modulation of type I interferon responses. However, the absence of multiple unrelated probands or extensive segregation data limits conclusive genetic correlation with COVID‑19. Additional investigations are required to better define the penetrance and expressivity of candidate variants in this gene.
Functional studies provide further insight into the biological plausibility of this association. Biophysical assessments have shown that TOMM70 engages with SARS‑CoV‑2 Orf9b, a viral accessory protein, which in turn may suppress the interferon response by altering the receptor's conformational dynamics (PMID:40027672, PMID:20504278). These experimental studies have characterized features such as the monomeric functional state of TOMM70 and the impact of lipid binding on its structure. Although a representative pathogenic variant (e.g., c.794C>T (p.Thr265Met)) has been reported in the context of mitochondrial disease, its candidacy in COVID‑19 has not been directly validated. Overall, the mechanistic data provide moderate functional support, even if the genetic evidence remains limited.
Gene–Disease AssociationLimitedLimited genetic evidence from candidate gene association studies in COVID‑19 cohorts (PMID:34530086, PMID:38902252) coupled with supportive functional data. Genetic EvidenceLimitedNo robust segregation or multiple unrelated proband evidence exists, although TOMM70 is repeatedly implicated in host interactome analyses for SARS‑CoV‑2. Functional EvidenceModerateBiophysical studies demonstrate that TOM70 interacts with SARS‑CoV‑2 Orf9b, altering the interferon response and supporting its plausible mechanistic role in COVID‑19 (PMID:40027672, PMID:20504278). |